Valued at USD 1.8 billion in 2025, the global robotics prosthetics market is projected to reach USD 4.6 billion by 2033, posting a robust ~12% CAGR as reimbursement widens and bionic components drop in cost. Growth outlook is underpinned by aging populations, rising diabetes-related amputations, and military demand for next-gen limbs, all converging to accelerate market forecast and industry expansion. Competitive intensity has sharpened through rapid FDA/CE clearances, driving a technology shift from myoelectric to machine-learning-enhanced neuro-controlled systems; meanwhile, supply-chain resilience is being stress-tested by semiconductor shortages and titanium alloy price volatility. North America retains the largest revenue share (≈42%), while Asia-Pacific is the fastest-growing region, fueled by government prosthetics subsidy schemes in China, India, and Japan.